Evidence map›Paper›PMID 34356116›Full record

ArticleGenes2021

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in

Marion Imbert-Bouteille, Carole Corsini, Marie-Christine Picot, Lucas Mizrahy, Sandrine Akouete, Helena Huguet, Frédéric Thomas, David Geneviève, Patrice Taourel, Marc Ychou and 12 more

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 3 countries.

Marion Imbert-BouteilleCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Carole CorsiniCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Marie-Christine PicotClinical Research and Epidemiology Unit, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Lucas MizrahyCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Sandrine AkoueteClinical Research and Epidemiology Unit, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Helena HuguetClinical Research and Epidemiology Unit, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Frédéric ThomasCNRS, Laboratory CREEC, MIVEGEC, IRD, 34394 Montpellier, France.ORCID 0000-0003-2238-1978
David GenevièveGenetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.ORCID 0000-0001-6928-6287
Patrice TaourelImagerie médicale, Montpellier, Université Montpellier, 34295 Montpellier, France.
Marc YchouDepartment of Oncology, ICM-Val d'Aurelle Cancer Center, 34298 Montpellier, France.
Virginie GalibertCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Chloé RideauCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Karen BaudryCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Tatiana Kogut KubiakCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Isabelle CoupierCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Rémy HobeikaCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Yvette MacaryCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.
Alain ToledanoOncology Department, Clinique Hartmann, 92309 Levallois, France.
Jérôme SolassolDepartment of Pathology and Onco-Biology, IRCM, ICM, CHU Montpellier, INSERM, Université Montpellier, 34295 Montpellier, France.ORCID 0000-0002-0293-6158
Antoine MaaloufGenetics Department, French Hospital du Levant, Beirut 50-226, Lebanon.
Jean-Pierre DauresBiostatistics Department, University of Montpellier I, CHU Montpellier, 34295 Montpellier, France.
Pascal PujolCancer Genetics Department, CHU Montpellier, Université Montpellier, 34295 Montpellier, France.ORCID 0000-0001-8315-4715
Université de Montpellier · FRCentre National de la Recherche Scientifique · FRClinique Hartmann · FRHôtel-Dieu de France · LBInserm · FRInstitut de Recherche en Cancérologie de Montpellier · FRUniversidade Federal de Juiz de Fora · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to clinical guidelines, the occurrence of very early-onset breast cancer (VEO-BC) (diagnosed ≤ age 30 years) or VEO ovarian cancer (VEO-OC) (diagnosed ≤ age 40 years) in families with

Indexed as

AdultAge of OnsetBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsFamilyFemaleFranceGenetic Predisposition to DiseaseHumansMiddle AgedMutationOvarian NeoplasmsRetrospective StudiesRisk FactorsYoung AdultBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanBRCA1BRCA2breast cancerearly-onsetovarian cancer

Identifiers

PMID34356116
PMCPMC8305427
OpenAlexW3185878136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.